NYSE:ZBHMedical Equipment
Zimmer Biomet Reshapes U.S. Sales Model As ROSA Knee Gains Ground
Zimmer Biomet Holdings (NYSE:ZBH) has launched a major reorganization of its U.S. salesforce, targeting a fully dedicated and specialized structure by 2027.
The company has also secured U.S. FDA clearance for an upgrade to its ROSA robotic-assisted knee system, expanding its capabilities in robotic knee procedures.
These moves come as Zimmer Biomet seeks to reshape its commercial model and product offering beyond routine quarterly results or share repurchases.
Zimmer Biomet enters this...